Company Filing History:
1 out of 3 
1 out of 6 Years Active: 2013
Title: Carmen Núñez Serrano: Innovator in Vaccine Technology
Introduction
Carmen Núñez Serrano is a prominent inventor based in Madrid, Spain. She has made significant contributions to the field of vaccine technology, particularly through her innovative work on fusion proteins that enhance the delivery of vaccine antigens to antigen-presenting cells. Her research has the potential to improve vaccine efficacy and broaden the scope of immunization strategies.
Latest Patents
Carmen holds a patent for a fusion protein that directs vaccine antigens to antigen-presenting cells. The patent, titled "Fusion protein with directioning of vaccinal antigens toward antigen-presenting cells and the applications thereof," describes a gene construct that includes at least one nucleotide sequence encoding a polypeptide with a specific region that recognizes the β chain of the class-II DR antigen on the surface of antigen-presenting cells. Additionally, it encompasses a nucleotide sequence that encodes a vaccinal antigen of interest. This invention also relates to recombinant vectors for expressing the gene construct, transgenic cells and plants transformed with these vectors, and vaccines that incorporate the fusion proteins.
Career Highlights
Throughout her career, Carmen has worked with notable institutions, including the Instituto Nacional de Investigación y Tecnología Agraria y Alimentaria and Alternative Gene Expression, S.L. Her work has been instrumental in advancing the understanding and application of genetic constructs in vaccine development.
Collaborations
Carmen has collaborated with esteemed colleagues such as José Angel Martínez Escribano and Andrés Wigdorovitz. These partnerships have contributed to her innovative research and the successful development of her patented technologies.
Conclusion
Carmen Núñez Serrano is a trailblazer in the field of vaccine technology, with her innovative patent showcasing her commitment to enhancing immunization strategies. Her work continues to inspire advancements in the medical and scientific communities.